MSME (Udyam registered) Ministry of MSME
- Category
- Small (2023-24)
- Udyam number
- UDYAM-CH-01-0004358
Lyra Laboratories Private Limited - pharma in Buranwala, Himachal Pradesh, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹24.06 Cr
▲ 1% YoY
Net profit · FY 2025
₹83.6 Lakh
Net margin 3.5%
EBITDA · FY 2025
₹1.72 Cr
EBITDA margin 7.1%
Authorised capital
₹70 Lakh
Registered with MCA
Paid-up capital
₹70 Lakh
Issued & subscribed
Open charges
₹14 Cr
Satisfied ₹8.19 Cr
Company age
21 yrs
Est. 2005
Employees · EPFO
2
Provident fund records
About Lyra Laboratories Private Limited
Data last updated:
Lyra Laboratories Private Limited is a private limited company based in Buranwala, Himachal Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 25 April 2005 and has been in existence for over 21 years.
The company is registered with the Registrar of Companies (ROC), Himachal Pradesh, under CIN U24230HP2005PTC028301. Its GSTIN is 02AABCL2964J1ZM (Himachal Pradesh). The company holds 5 GST registrations, of which 2 are active.
The company has an authorised share capital of ₹70 Lakh and a paid-up capital of ₹70 Lakh. It is led by directors Dharmender Singh Gulati and Jaspreet Singh Gulati.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Baddi Barotiwala Road, Buranwala, Himachal Pradesh, India – 174103.
As per the financials filed for FY 2025, the company reported a revenue of ₹24.06 Cr, a growth of 1% compared to the previous year. For the same year it recorded a net profit of ₹83.6 Lakh (net margin 3.5%) and EBITDA of ₹1.72 Cr (EBITDA margin 7.1%). Revenue has grown at a compounded annual rate (CAGR) of 15% over three years and 9% over five years.
The company has about 2 employees on its provident fund (EPFO) records.
The company is associated with 2 brands: Ceuticoz and Lyra Laboratories. As per MCA filings, the company has open charges of ₹14 Cr and satisfied charges of ₹8.19 Cr on record. Court records list 5 cases involving the company, including 5 filed against it; 1 case is pending.
Lyra Laboratories Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-CH-01-0004358). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website lyralab.com.
Company details
CIN U24230HP2005PTC028301
Registration Number 028301
Incorporation Date 25 April 2005
ROC Himachal Pradesh
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-CH-01-0004358
Recognitions & Rankings of Lyra Laboratories
Contact details
Lyra Laboratories Private Limited's registered office is in Buranwala, Himachal Pradesh. Its website is lyralab.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressBaddi Barotiwala Road, Buranwala, Himachal Pradesh, India – 174103
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Lyra Laboratories Private Limited, buy the company report.
Comprehensive company report
Lyra Laboratories Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Lyra Laboratories operates two associated brands: Ceuticoz and Lyra Laboratories. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Offers effective skincare and haircare solutions using science-driven formulations. | ceuticoz.com | |
| Lyra Laboratories develops and manufactures dermatology products for contract and franchise in India. | lyralab.com |
Business activity
The main business activity of Lyra Laboratories is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Lyra Laboratories Private Limited, buy the company report.
Financials of Lyra Laboratories Private Limited
FY 2025 filings availableLyra Laboratories Private Limited reported revenue of ₹24.06 Cr (up 1% YoY) for FY 2025.
Revenue · FY 2025
₹24.06 Cr ▲ 1%
Net profit · FY 2025
₹83.6 Lakh margin 3.5%
EBITDA · FY 2025
₹1.72 Cr margin 7.1%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 1%
3 years · compounded
▲ 15%
5 years · compounded
▲ 9%
EBITDA CAGR growth
1 year
▼ 3%
3 years · compounded
▲ 23%
5 years · compounded
▲ 6%
Revenue has grown at a compounded annual rate (CAGR) of 9% over five years, including 1% growth in the latest year. EBITDA fell 3% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.72 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹83.6 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 7.1% | ||||
| Net Profit Margin | 3.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Lyra Laboratories Private Limited, buy the company report.
Board of directors of Lyra Laboratories Private Limited
Lyra Laboratories has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Dharmender Singh Gulati Also directs: Quencil Research Private Limited, Re'equil India Private Limited, Hi-Tech Formulations Private Limited and 2 more | Director | 25 May 2011 | 15 Years 4 Months | Current |
| Jaspreet Singh Gulati | Director | 31 Dec 2012 | 13 Years 9 Months | Current |
Peer comparison
Lyra Laboratories Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Contract Research, Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Alchemy Medicine Private Limited | ₹24.15 Cr (FY 2025) | 28.0% | New Delhi, Delhi, India | |||
| Dagon Pharmaceuticals Private Limited | ₹24.08 Cr (FY 2025) | 3.0% | Vadodara, Gujarat, India | |||
| Lyra Laboratories Private Limitedthis company | ₹24.06 Cr (FY 2025) | ₹83.6 Lakh | 3.5% | 1.0% | 2 | Buranwala, Himachal Pradesh, India |
| Cosmas Pharmacls Limited | ₹23.95 Cr (FY 2025) | 1.0% | Ludhiana, Punjab, India | |||
| Decipher Labs Limited | ₹23.93 Cr (FY 2025) | -34.0% | Hyderabad, Telangana, India | |||
| Vivek Pharmaceuticals Private Limited | ₹23.84 Cr (FY 2024) | Jaipur, Rajasthan, India | ||||
| Chemgenix Laboratories Private Limited | ₹23.72 Cr (FY 2025) | -1.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Lyra Laboratories Private Limited, buy the company report.
Auditor
Lyra Laboratories Private Limited is audited by Gambhir Khurana & Associates for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Gambhir Khurana & Associates | FY 2022 | 012599N |
Shareholding
The shareholding of Lyra Laboratories Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Lyra Laboratories Private Limited, buy the company report.
Charges & borrowings
Open charges
₹14 Cr
Satisfied charges
₹8.19 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 18 Oct 2025 | 101179291 | Bank of India | ₹9 Cr | Open | |
| 23 Jul 2021 | 100469612 | Others | ₹5 Cr | Open | |
| 08 Jun 2023 | 100735304 | Others | ₹6 Cr | Satisfied | |
| 25 Oct 2018 | 100231199 | Hdfc Bank Limited | ₹78 Lakh | Satisfied | |
| 27 Nov 2014 | 10538283 | Punjab National Bank | ₹6 Lakh | Satisfied |
To see the full charge records of Lyra Laboratories Private Limited, buy the company report.
Total charge records: 7 View all charges
Legal cases
Lyra Laboratories Private Limited has 5 court cases on record: 5 filed against it. 1 case is pending and 4 are disposed.
Total cases
5
Filed against the company
5
Pending
1
Disposed
4
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 3 | 3 | 0 |
| District courts | 2 | 2 | 1 |
Cases on record (5 of 5)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Kumuram Bheem Asifabad, Telangana | Court case (PRC) | Filed against the company | Pending |
| District court, Kumuram Bheem Asifabad, Telangana | Criminal complaint | Filed against the company | Disposed |
| High Court, TAMIL NADU | Appeal | Filed against the company by M/S.Stedman Pharmaceutials P.L | Disposed |
| High Court, TAMIL NADU | Original application | Filed against the company by M/S.Stedman Pharmaceuticals | Disposed |
| High Court, TAMIL NADU | Civil suit | Filed against the company by M/S.Stedman Pharmaceuticals P | Disposed |
To see the full case history of Lyra Laboratories Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Lyra Laboratories Private Limited has 1 MSME Form 1 return on record for the period ending Mar 2019, listing 10 overdue payments to 3 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (3 of 3)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Nano Tech Chemical Brothers Private Limited | |||
| Red Packing Solutions Private Limited | |||
| Synergene Active Ingredients Private Limited |
To see the full MSME payment records of Lyra Laboratories Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Lyra Laboratories Private Limited has a workforce of 2 employees on its EPFO records as of Apr 08, 2024, across 1 active EPFO establishment.
Employee count
2
Active EPFO establishments
1
Employee growth
-50%
GST
Lyra Laboratories has 5 GST registrations: 2 active and 3 cancelled or inactive.
Total GSTINs
5
Active
2
Cancelled / inactive
3
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 02AABCL2964J1ZM | Himachal Pradesh | Active | 01 Jul 2017 |
| 04AABCL2964J2ZH | Chandigarh | Active | 11 Dec 2020 |
To see the full GST registrations and return filing status of Lyra Laboratories Private Limited, buy the company report.
Recent activity
Lyra Laboratories Private Limited has 10 board changes on record since 2005: 6 appointments and 4 cessations. The latest: Inderjit Singh ceased to be Director on 22 Oct 2019.
Charges
A charge with Bank Of India amounted to Rs. 900.00 Lakh with Charge ID 101179291 was registered on 18 Oct 2025.
AGM
Lyra Laboratories Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Lyra Laboratories Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Himachal Pradesh.
Charges
A charge registered on 08 Jun 2023 via Charge ID 100735304 with Others was fully satisfied on 13 Dec 2024.
Charges
A charge with Others of Rs. 500.00 Lakh registered on 23 Jul 2021 with Charge ID 100469612 was modified on 14 Aug 2023.
Charges
A charge with Others amounted to Rs. 600.00 Lakh with Charge ID 100735304 was registered on 08 Jun 2023.
Charges
A charge registered on 27 Nov 2014 via Charge ID 10538283 with Punjab National Bank was fully satisfied on 02 Aug 2021.
Charges
A charge registered on 18 Dec 2010 via Charge ID 10265568 with Punjab National Bank was fully satisfied on 02 Aug 2021.
Charges
A charge registered on 23 Aug 2005 via Charge ID 80045934 with Punjab National Bank was fully satisfied on 02 Aug 2021.
Charges
A charge with Others amounted to Rs. 500.00 Lakh with Charge ID 100469612 was registered on 23 Jul 2021.
Charges
A charge registered on 25 Oct 2018 via Charge ID 100231199 with Hdfc Bank Limited was fully satisfied on 12 Mar 2020.
Ceased
Inderjit Singh ceased to be Director.
15 earlier events are in the company report.
Frequently asked questions
Lyra Laboratories is an active private limited company based in Buranwala, Himachal Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 25 April 2005 (21+ years old) and is registered under CIN U24230HP2005PTC028301.
Lyra Laboratories has 2 current directors:
- Dharmender Singh Gulati - Director
- Jaspreet Singh Gulati - Director
The latest financial statements of Lyra Laboratories on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Lyra Laboratories is 02AABCL2964J1ZM, registered in Himachal Pradesh. The company has 5 GST registrations in all, of which 2 are active and 3 are cancelled or inactive. Other active GSTINs include 04AABCL2964J2ZH (Chandigarh).
The CIN (Corporate Identification Number) of Lyra Laboratories is U24230HP2005PTC028301. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Lyra Laboratories has 5 court cases on record: 5 filed against it. 1 is pending. Most are in the high courts.
Lyra Laboratories was incorporated on 25 April 2005, making it 21+ years old. It is registered with the Registrar of Companies, Himachal Pradesh.
The peers of Lyra Laboratories by revenue are Alchemy Medicine Private Limited, Dagon Pharmaceuticals Private Limited, Cosmas Pharmacls Limited, Decipher Labs Limited, Vivek Pharmaceuticals Private Limited and 1 more, all in the Pharma industry (Contract Research, Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Inderjit Singh ceased to be Director on 22 Oct 2019. Gurbax Singh ceased to be Director on 31 Dec 2012. Jaspreet Singh Gulati was appointed as Director on 31 Dec 2012. Lyra Laboratories has 10 board changes on record in total.
Yes, Lyra Laboratories is registered as a small enterprise under Udyam registration (number: UDYAM-CH-01-0004358).
Lyra Laboratories has 1 MSME Form 1 return on record for the period ending Mar 2019, listing 10 overdue payments to 3 micro and small suppliers. The latest return was filed on 18 Jun 2019.
Lyra Laboratories can be reached through the website lyralab.com. Its registered office is in Buranwala, Himachal Pradesh, India.